BlackRock, Inc. 13D and 13G filings for Harvard Bioscience, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-07-17 8:12 pm Sale | 2025-06-30 | 13G | HAVARD BIOSCIENCE INC HBIO | BlackRock Inc. BLK | 111,393 2.500% | -179,988 (-61.77%) | Filing |
| 2024-01-26 5:26 pm Purchase | 2023-12-31 | 13G | HAVARD BIOSCIENCE INC HBIO | BlackRock Inc. BLK | 291,381 6.800% | 170,469 (+140.99%) | Filing |
| 2022-07-08 4:57 pm Sale | 2022-06-30 | 13G | HAVARD BIOSCIENCE INC HBIO | BlackRock Inc. BLK | 120,912 2.900% | -185,407 (-60.53%) | Filing |
| 2022-02-02 7:11 pm Purchase | 2021-12-31 | 13G | HAVARD BIOSCIENCE INC HBIO | BlackRock Inc. BLK | 306,319 7.500% | 10,928 (+3.70%) | Filing |